Lv2
158 积分 2025-04-02 加入
Synthetic Approaches to the New Drugs Approved During 2024
1个月前
已完结
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR
1个月前
已完结
Disrupted molecular glue complex drives RAS inhibitor resistance
2个月前
已完结
PROTACs: past, present and future
2个月前
已完结
Chemistries of bifunctional PROTAC degraders
2个月前
已完结
Biocatalytic cascades enable manufacture of the macrocyclic peptide enlicitide
2个月前
已完结
The Affinity Advantage
5个月前
已完结
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
6个月前
已完结
Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome
6个月前
已完结
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
6个月前
已完结
皖公网安备34019202002308
